Dr. Ryan has consistently been an active participant in buying and selling shares of Gevo, illustrating his belief in the company's potential. Notably, he traded sizable amounts in 2021, reaching peaks with sales exceeding $7 million in a single month....
Dr. Ryan has consistently been an active participant in buying and selling shares of Gevo, illustrating his belief in the company's potential. Notably, he traded sizable amounts in 2021, reaching peaks with sales exceeding $7 million in a single month. Since then, his trading activity has shown a more cautious approach, with several months seeing transactions around the $1 million mark in 2023, reflecting ongoing confidence in Gevo amid market fluctuations. His total stock grants show a trend towards building significant equity in the company, which has grown as the company’s prospects have improved.